Exactly. Thanks. I also think we know it’s unlikely, and we know the endpoints have been changed. But we also know the FDA maintains maximum flexibility on these matters.
Almost nothing can be certain until we know and the Company, I believe will do their best to inform us as quickly as they can, once they have an adequate analysis by their panel of experts and they have carefully crafted their plan for a factually accurate and complete reveal.
No 4 day rule applies, but clearly they are still subject to the normal fraud protections for investors, broadly speaking. It’s a complex dance. Early disclosure is the best policy, but it is not always possible to be accurate without careful review if the data and the ultimate statement by the relevant, important stakeholders and experts.
Market Data 
Markets 
AI
